253 related articles for article (PubMed ID: 27566310)
1. Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cm.
Guarneri A; Franco P; Trino E; Campion D; Faletti R; Mirabella S; Gaia S; Ragona R; Diotallevi M; Saracco G; Salizzoni M; Ricardi U; Carucci P
Med Oncol; 2016 Oct; 33(10):104. PubMed ID: 27566310
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic ablative radiation therapy prior to liver transplantation in hepatocellular carcinoma.
Guarneri A; Franco P; Romagnoli R; Trino E; Mirabella S; Molinaro L; Rizza G; Filippi AR; Carucci P; Salizzoni M; Ricardi U
Radiol Med; 2016 Nov; 121(11):873-881. PubMed ID: 27447803
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy in hepatocellular carcinoma: patient selection and predictors of outcome and toxicity.
Loi M; Comito T; Franzese C; Dominici L; Lo Faro L; Clerici E; Franceschini D; Mancosu P; Reggiori G; Gallo P; Badalamenti M; Scorsetti M
J Cancer Res Clin Oncol; 2021 Mar; 147(3):927-936. PubMed ID: 32945972
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma.
Takeda A; Sanuki N; Eriguchi T; Kobayashi T; Iwabutchi S; Matsunaga K; Mizuno T; Yashiro K; Nisimura S; Kunieda E
J Gastroenterol Hepatol; 2014 Feb; 29(2):372-9. PubMed ID: 23927053
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Survival Analysis of Stereotactic Ablative Radiotherapy Versus Liver Resection for Small Hepatocellular Carcinoma.
Su TS; Liang P; Liang J; Lu HZ; Jiang HY; Cheng T; Huang Y; Tang Y; Deng X
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):639-646. PubMed ID: 28581406
[TBL] [Abstract][Full Text] [Related]
6. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis.
Yang JF; Lo CH; Lee MS; Lin CS; Dai YH; Shen PC; Chao HL; Huang WY
Radiat Oncol; 2019 Oct; 14(1):180. PubMed ID: 31640728
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y
Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.
Boda-Heggemann J; Dinter D; Weiss C; Frauenfeld A; Siebenlist K; Attenberger U; Ottstadt M; Schneider F; Hofheinz RD; Wenz F; Lohr F
Radiat Oncol; 2012 Jun; 7():92. PubMed ID: 22710033
[TBL] [Abstract][Full Text] [Related]
10. Repeated stereotactic ablative radiotherapy using CyberKnife for patients with hepatocellular carcinoma.
Lo CH; Huang WY; Lin KT; Lin MJ; Lin TP; Jen YM
J Gastroenterol Hepatol; 2014 Nov; 29(11):1919-25. PubMed ID: 25041220
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of local control, survival and toxicity outcomes.
Shanker MD; Moodaley P; Soon W; Liu HY; Lee YY; Pryor DI
J Med Imaging Radiat Oncol; 2021 Dec; 65(7):956-968. PubMed ID: 34396706
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic ablative radiotherapy for unresectable hepatocellular carcinoma patients who failed or were unsuitable for transarterial chemoembolization.
Lo CH; Huang WY; Lee MS; Lin KT; Lin TP; Chang PY; Fan CY; Jen YM
Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):345-52. PubMed ID: 24384685
[TBL] [Abstract][Full Text] [Related]
13. Image-guided stereotactic ablative radiotherapy for the liver: a safe and effective treatment.
Van De Voorde L; Vanneste B; Houben R; Damen P; van den Bogaard J; Lammering G; Dejong K; de Vos-Geelen J; Buijsen J; Öllers M; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Feb; 41(2):249-56. PubMed ID: 25468743
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients.
Sanuki N; Takeda A; Oku Y; Mizuno T; Aoki Y; Eriguchi T; Iwabuchi S; Kunieda E
Acta Oncol; 2014 Mar; 53(3):399-404. PubMed ID: 23962244
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases.
Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U
Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of stereotactic body radiation therapy for small hepatocellular carcinoma.
Park S; Jung J; Cho B; Kim SY; Yun SC; Lim YS; Lee HC; Park J; Park JH; Kim JH; Yoon SM
J Gastroenterol Hepatol; 2020 Nov; 35(11):1953-1959. PubMed ID: 32052884
[TBL] [Abstract][Full Text] [Related]
18. Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study.
Su TS; Liu QH; Zhu XF; Liang P; Liang SX; Lai L; Zhou Y; Huang Y; Cheng T; Li LQ
Radiat Oncol; 2021 Apr; 16(1):79. PubMed ID: 33882972
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma.
Jeong Y; Jung J; Cho B; Kwak J; Jeong C; Kim JH; Park JH; Kim SY; Shim JH; Kim KM; Lim YS; Lee HC; Yoon SM
BMC Cancer; 2018 Apr; 18(1):416. PubMed ID: 29653562
[TBL] [Abstract][Full Text] [Related]
20. Two-week schedule of hypofractionated radiotherapy as a local salvage treatment for small hepatocellular carcinoma.
Park JH; Yoon SM; Lim YS; Kim SY; Shim JH; Kim KM; Lee HC; Cho B; Park G; Kim JH
J Gastroenterol Hepatol; 2013 Oct; 28(10):1638-42. PubMed ID: 23621519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
